DexCom
DXCM
282 hedge funds and large institutions have $6.36B invested in DexCom in 2015 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 89 increasing their positions, 123 reducing their positions, and 24 closing their positions.
108% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 24
9% more funds holding
Funds holding: 258 → 282 (+24)
7% more capital invested
Capital invested by funds: $5.97B → $6.36B (+$390M)
7% more call options, than puts
Call options by funds: $49.7M | Put options by funds: $46.3M
28% less repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 123
45% less funds holding in top 10
Funds holding in top 10: 11 → 6 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$297M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
+$104M |
| 3 |
Morgan Stanley
New York
|
+$94.9M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$73M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$55.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$197M |
| 2 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$80M |
| 3 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$69.7M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$64.2M |
| 5 |
O
OppenheimerFunds
New York
|
-$57.5M |
DXCM Hedge Fund Activity: Q3 2015 in Review
282 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q3 2015, worth a combined $6.36B — up 6.5% from $5.97B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new DXCM positions and 24 closed out — a net gain of 26 holders — while 89 added to existing stakes and 123 trimmed.
The largest buyer was Ameriprise, adding an estimated $297M. The largest seller was Wellington Management Group, cutting an estimated $197M.
- 282 institutional investors held DexCom (DXCM) as of Q3 2015, up from 258 in Q2 2015.
- Funds reported $6.36B of DexCom stock for Q3 2015, up 6.5% quarter-over-quarter.
- 50 funds opened new DexCom positions in Q3 2015 and 24 closed out, a net change of +26 holders.
- The largest DexCom buyer in Q3 2015 was Ameriprise, an estimated $297M added.
- The largest DexCom seller in Q3 2015 was Wellington Management Group, an estimated $197M sold.
Based on aggregated 13F filings for Q3 2015.